NCT00575003

Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis

Double-Blind, Placebo-Controlled Study to Investigate an Immunomodulatory Therapy (CYT003-QbG10) in Adult Patients With Perennial Allergic Rhinoconjunctivitis

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 64 (estimated)
• Sponsor: Cytos Biotechnology AG · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The purpose of the study is to test the efficacy of a vaccine against house dust mite and/or cat allergy compared to placebo in adult patients.

Conditions

• Perennial Allergy to House Dust Mite and/or Cat

Interventions

Type	Name	Description
DRUG	CYT003-QbG10	6 subcutaneous injections

Timeline

• Start date: 2007-12-01
• Primary completion: 2009-03-01
• Completion: 2009-03-01
• First posted: 2007-12-17
• Last updated: 2009-04-27

Locations

7 sites across 3 countries: Estonia, Latvia, Lithuania